<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href='static/style.xsl' type='text/xsl'?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-22T10:23:58Z</responseDate><request verb="GetRecord" identifier="oai:ecommons.cornell.edu:1813/102900" metadataPrefix="dim">https://ecommons.cornell.edu/server/oai/request</request><GetRecord><record><header><identifier>oai:ecommons.cornell.edu:1813/102900</identifier><datestamp>2026-05-15T19:50:14Z</datestamp><setSpec>com_1813_35</setSpec><setSpec>col_1813_47</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="author">Mosquera, Matthew J</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="chair">Singh, Ankur</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="committeeMember">Brito, Ilana Lauren</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="committeeMember">Putnam, David A.</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2021-03-12T17:38:38Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2022-08-27T06:00:27Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2020-08</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other">ProQuest Submission ID: 12247</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other">ProQuest Publication ID: 28089076</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://hdl.handle.net/1813/102900</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="doi">https://doi.org/10.7298/em02-tv25</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="bibid">13277882</dim:field>
   <dim:field mdschema="dc" element="description">146 pages</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract">Engineered biomaterials have great versatility in addressing disease conditions, with applications ranging from drug delivery to engineered implants. However, an outstanding question remains whether the underlying patient disease can impact the body’s response to these engineered materials and, if so, how new materials can be designed to account for this underlying heterogeneity. In my work, I present two parallel approaches to address this outstanding question: first by studying the impact of gut microbiome-mediated metabolic syndrome effect on engineered vaccines and next, by developing modular hydrogel organoid platform to grow patient-derived prostate tumors and study the role of disease heterogeneity on cancer progression, mechanotransduction and signaling pathways, and therapeutic outcomes.</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso">en</dim:field>
   <dim:field mdschema="dc" element="subject">Cancer</dim:field>
   <dim:field mdschema="dc" element="subject">Immunology</dim:field>
   <dim:field mdschema="dc" element="subject">Metabolic Syndrome</dim:field>
   <dim:field mdschema="dc" element="subject">Prostate Cancer</dim:field>
   <dim:field mdschema="dc" element="subject">Tissue Engineering</dim:field>
   <dim:field mdschema="dc" element="subject">Vaccine</dim:field>
   <dim:field mdschema="dc" element="title">Bioengineered Materials to Address Disease-Specific Response in Humoral Immunity and Cancer</dim:field>
   <dim:field mdschema="dc" element="type">dissertation or thesis</dim:field>
   <dim:field mdschema="dc" element="relation" qualifier="localuri">https://catalog.library.cornell.edu/catalog/13277882</dim:field>
   <dim:field mdschema="dc" element="format" qualifier="mimetype">application/pdf</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="discipline">Mechanical Engineering</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="grantor">Cornell University</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="level">Doctor of Philosophy</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="name">Ph. D., Mechanical Engineering</dim:field>
   <dim:field mdschema="dcterms" element="license">https://hdl.handle.net/1813/59810</dim:field>
   <dim:field mdschema="dspace" element="entity" qualifier="type">Publication</dim:field>
   <dim:field mdschema="cris" element="virtual" qualifier="collection" authority="https://cornell-ecommons.eks.prod.4science.cloud/handle/1813/47" confidence="600">Cornell Theses and Dissertations</dim:field>
   <dim:field mdschema="cris" element="virtual" qualifier="author">Mosquera, Matthew J</dim:field>
   <dim:field mdschema="cris" element="virtualsource" qualifier="collection">5893a6ea-7af3-41d7-abc6-04bcd26ab5df</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
   <dim:field mdschema="cerif" element="openaire" authority="" confidence="-1">&lt;Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="3c1d1354-5775-4e55-bcce-87795a9cddfb">
	&lt;Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843&lt;/Type>
	&lt;Language>en&lt;/Language>
   	&lt;Title>Bioengineered Materials to Address Disease-Specific Response in Humoral Immunity and Cancer&lt;/Title>
   	&lt;PublishedIn>
    	&lt;Publication>
      	&lt;/Publication>
   	&lt;/PublishedIn>
   	&lt;PublicationDate>2020-08&lt;/PublicationDate>
   	&lt;DOI>https://doi.org/10.7298/em02-tv25&lt;/DOI>
   	&lt;Authors>
      	&lt;Author>
        	&lt;DisplayName>Mosquera, Matthew J&lt;/DisplayName>
         	&lt;Affiliation>
         		&lt;OrgUnit>
         		&lt;/OrgUnit>
         	&lt;/Affiliation>
      	&lt;/Author>
	&lt;/Authors>
   	&lt;Editors>
	&lt;/Editors>
    &lt;Publishers>
        &lt;Publisher>
            &lt;OrgUnit />
        &lt;/Publisher>
    &lt;/Publishers>
    &lt;Keyword>Cancer&lt;/Keyword>
    &lt;Keyword>Immunology&lt;/Keyword>
    &lt;Keyword>Metabolic Syndrome&lt;/Keyword>
    &lt;Keyword>Prostate Cancer&lt;/Keyword&gt;
    &lt;Keyword>Tissue Engineering&lt;/Keyword>
    &lt;Keyword>Vaccine&lt;/Keyword>
   	&lt;Abstract>Engineered biomaterials have great versatility in addressing disease conditions, with applications ranging from drug delivery to engineered implants. However, an outstanding question remains whether the underlying patient disease can impact the body’s response to these engineered materials and, if so, how new materials can be designed to account for this underlying heterogeneity. In my work, I present two parallel approaches to address this outstanding question: first by studying the impact of gut microbiome-mediated metabolic syndrome effect on engineered vaccines and next, by developing modular hydrogel organoid platform to grow patient-derived prostate tumors and study the role of disease heterogeneity on cancer progression, mechanotransduction and signaling pathways, and therapeutic outcomes.&lt;/Abstract>
	&lt;Access xmlns="http://purl.org/coar/access_right" 
    >
    &lt;/Access>
&lt;/Publication>
</dim:field>
</dim:dim>
</metadata></record></GetRecord></OAI-PMH>